Zenith Health Care approves amalgamation with Achyut Healthcare
Zenith Health Care approved amalgamating Achyut Healthcare to boost efficiency and simplify structure. The deal involves issuing 119 shares for every 50 shares held, pending regulatory approvals.
*this image is generated using AI for illustrative purposes only.
Zenith Health Care Ltd has approved a scheme to amalgamate Achyut Healthcare Limited with and into the company to enhance operational efficiency and simplify the group structure. The board approved the merger at its meeting held on July 14, 2026, following recommendations from the Audit Committee and the Committee of Independent Directors. The amalgamation will result in the issuance of equity shares by Zenith Health Care to the shareholders of Achyut Healthcare, which will subsequently dissolve without winding up.
The transaction is classified as a related party transaction as both entities fall under the same promoter group. However, the consideration will be discharged on an arm's length basis based on a valuation report dated July 14, 2026 from Den Valuation (OPC) Private Limited and Vanshika Vijayvargiy. Aftertrade Broking Private Limited also issued a fairness opinion regarding the share exchange ratio. The scheme is subject to requisite approvals from statutory and regulatory authorities, including the jurisdictional bench of the National Company Law Tribunal (NCLT), as well as shareholder and creditor consent.
Share Exchange Ratio and Financials
No cash consideration is payable under the scheme. Upon effectiveness, Zenith Health Care will issue 119 fully paid-up equity shares of INR 1 each for every 50 fully paid-up equity shares of INR 1 each held in Achyut Healthcare. As of March 31, 2026, Achyut Healthcare reported total assets of INR 3809.44 lakhs and a net worth of INR 3506.12 lakhs, while Zenith Health Care reported total assets of INR 1098.59 lakhs and a net worth of INR 742.42 lakhs.
Rationale and Synergies
The merger aims to combine the businesses of both companies, which operate in similar pharmaceutical sectors. Achyut Healthcare is engaged in trading active pharmaceutical ingredients (APIs) and is establishing manufacturing facilities for tablets, capsules, and inhalation products. Zenith Health Care manufactures and exports pharmaceutical products, including tablets, capsules, and oral liquids, to 11 countries. The amalgamation is expected to unlock new market opportunities, optimize manufacturing capacity, and create a stronger balance sheet for the combined entity.
Shareholding Pattern
The amalgamation will alter the shareholding pattern of Zenith Health Care significantly. The total number of shares will increase from 5,37,39,000 to 62,81,68,660. Promoter holding is set to rise from 28.74% to 45.80%, while public shareholding will decrease from 71.26% to 54.20%.
| Category | Pre Amalgamation | Post Amalgamation | ||
|---|---|---|---|---|
| No. of shares | % share holding | No. of shares | % share holding | |
| Promoter | 1,54,43,579 | 28.74% | 28,77,22,683 | 45.80% |
| Public | 3,82,95,421 | 71.26% | 34,04,45,977 | 54.20% |
| Total | 5,37,39,000 | 100% | 62,81,68,660 | 100% |
The scheme will be filed with BSE Limited to obtain a no-objection letter. Both companies will comply with requirements for providing e-voting facilities, acting on the scheme only if public shareholder votes in favour exceed those against it.
Historical Stock Returns for Zenith Health Care
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.92% | -1.54% | +3.24% | -6.73% | -20.65% | -60.47% |
How will the significant dilution of public shareholding impact the stock's liquidity and retail investor sentiment?
What specific regulatory challenges might arise given the substantial increase in promoter holding to 45.80%?
How does the merged entity plan to leverage the expanded balance sheet to fund Achyut Healthcare's upcoming manufacturing facilities?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
